Today, cybersecurity firm Illusive Networks announced a significant USD22 million Series B round. Bizjournals said that the Israeli firm raised the amount just four months shy of its Series A, which picked up USD5 million in funding.
The Series B funding was led by New Enterprise Associates, a new investor, and participated by Bessemer Venture Partners, Citi Ventures, Marker LLC, and Innovation Endeavors, Geektime said. Innovation Endeavors is reportedly founded in part by Google’s Eric Schmidt.
Illusive’s primary product is called Deceptions EverywhereTM approach, of which relies on deceptions that have been installed everywhere on a customer’s network, TechCrunch said. If an enterprising hacker acts or stumbles on the deceptions, it automatically launches a forensic application providing clients an opportunity to detect and take control of the situation while minimizing the effects of the attack.
Illusive VP of R&D Ofer Israeli told Geektime, “The Series B funding provides resources to scale more quickly. A year from now illusive networks will be protecting more customers, in more countries, in more market segments, using new counter measure deceptions to security problems that have not yet been envisioned by advanced hackers. Cyber attacks and cyber criminals are constantly changing their attack methods, [and] illusive will constantly evolve to block them.”


SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
Apple Turns 50: From Garage Startup to AI Crossroads
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook 



